Please login to the form below

Not currently logged in
Email:
Password:

Relvar

This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs GSK's asthma drug Breo for adults only

FDA panel backs GSK's asthma drug Breo for adults only

The product is sold as Relvar in some markets and is a follow-up to GSK's blockbuster Seretide/Advair product and combines LABA vilanterol with the inhaled corticosteroid (ICS) fluticasone

Latest news

  • GSK replaces head of US operations GSK replaces head of US operations

    up Relvar/Breo (fluticasone furoate and vilanterol) - to get off to a flying start in the increasingly competitive respiratory sector.

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    combination Anoro (umeclidinium and vilanterol) and Advair follow-up Relvar/Breo (fluticasone furoate and vilanterol) - to get the division back on track.

  • GSK trial throws everything at COPD GSK trial throws everything at COPD

    All three drugs will be delivering via GSK's Ellipta inhaler, which is already used in the company's recently introduced dual therapies Anoro (umeclidinium and vilanterol) and Relvar/Breo (fluticasone

  • SMC: Celgene's Abraxane 'too expensive' for Scotland SMC: Celgene's Abraxane 'too expensive' for Scotland

    SMC: Celgene's Abraxane 'too expensive' for Scotland. But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta. ... Drugs that received positive opinions included Janssen's Invokana (canagliflozin) for type 2 diabetes, Jazz

  • GSK clear to launch COPD hope Anoro in Europe GSK clear to launch COPD hope Anoro in Europe

    GSK needs its new respiratory products - which also include Theravance-partnered combination LABA and steroid drug Breo/Relvar (vilanterol and fluticasone) - if it is to lessen the impact of emerging competition

More from news
Approximately 2 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Uptake Strategies

We are a specialist healthcare marketing consultancy generating competitive strategies underpinned with excellent customer insight, clear objectives and measures of...

Latest intelligence

Capturing "in-the-moment" patient and physician insights
Utilising the benefits of mobile technology...
Webinar: Observational Research
Presenting a window on the world of your customer...
Webinar: The Brazil Conundrum
Conducting research in one of the world's largest pharma markets...